Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. [electronic resource]
Producer: 20000419Description: 652-9 p. digitalISSN:- 0006-291X
- Amides -- pharmacology
- Animals
- Azepines -- pharmacology
- Cattle
- Cell Division -- drug effects
- Cells, Cultured
- Chemotaxis -- drug effects
- Endothelium, Vascular -- drug effects
- Enzyme Inhibitors -- pharmacology
- Humans
- Intracellular Signaling Peptides and Proteins
- Male
- Mice
- Mice, Transgenic
- Myosin-Light-Chain Kinase -- antagonists & inhibitors
- Myosin-Light-Chain Phosphatase
- Neoplasm Invasiveness -- prevention & control
- Neoplasm Metastasis -- prevention & control
- Neovascularization, Physiologic -- drug effects
- Phosphoprotein Phosphatases -- antagonists & inhibitors
- Prostatic Neoplasms -- pathology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyridines -- pharmacology
- Transplantation, Heterologous
- Tumor Cells, Cultured
- rho-Associated Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.